Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 23 January

Bell Direct
January 23, 2024

Morning Bell 22 January

Bell Direct
January 22, 2024

Weekly Wrap 19 January

Bell Direct
January 19, 2024

Morning Bell 19 January

Bell Direct
January 19, 2024

Morning Bell 18 January

Bell Direct
January 18, 2024

Morning Bell 17 January

Bell Direct
January 17, 2024

Morning Bell 16 January

Bell Direct
January 16, 2024

Morning Bell 15 January

Sophia Mavridis
January 15, 2024

Weekly Wrap 15 December

Bell Direct
December 15, 2023

Morning Bell 14 December

Bell Direct
December 14, 2023

Morning Bell 13 December

Bell Direct
December 13, 2023